| Issue Date | Title | Author(s) |
| 2008-01 | Método Dáder Para El Seguimiento Farmacoterapéutico En La Atención Hospitalaria | Silva-Castro, MM; Calleja-Hernandez, MA; Tuneu, I; Valls, L; Machuca, M; Sabater Hernandez, D; Faus, MJ; Silva Castro, MM; Calleja Hernandez, MA; Tuneu, I; Valls, L; Faus Dader, MJ |
| 2006-09-01 | Toll-like receptor 2, 3, and 4 expression and function in human airway smooth muscle | Sukkar, MB; Xie, S; Khorasani, NM; Kon, OM; Stanbridge, R; Issa, R; Chung, KF |
| 2008-01-01 | Anticoagulation control in hospitalised patients on warfarin | Su, EY; Naganathan, V; Fallah, H; Bajorek, BV; McLachlan, AJ |
| 2009-10-01 | Therapy for Triggered Acute Risk Prevention: A Study of Feasibility | Shaw, E; Tofler, GH; Buckley, T; Bajorek, B; Ward, M |
| 2008-03-12 | Structure and organization of phospholipid/polysaccharide nanoparticles | Gerelli, Y; Di Bari, MT; Deriu, A; Cantu, L; Colombo, P; Como, C; Motta, S; Sonvico, F; May, R |
| 2008-01-01 | Exploring point-of-care testing of capillary blood in warfarin management | Glover, S; Bajorek, BV |
| 2008-08-01 | Treating asthma means treating airway smooth muscle cells | Zuyderduyn, S; Sukkar, MB; Fust, A; Dhaliwal, S; Burgess, JK |
| 2009-01-01 | Management of over-anticoagulation in warfarinised hospital patients | Bajorek, BV; Yau, L; Lee, K; Zulueta, W |
| 2009-01-01 | Balancing risk versus benefit: The elderly patient's perspective on warfarin therapy | Bajorek, BV; Ogle, SJ; Duguid, MJ; Shenfield, GM; Krass, I |
| 2008-04-01 | Fluticasone, but not salmeterol, reduces cigarette smoke-induced production of interleukin-8 in human airway smooth muscle | Oltmanns, U; Walters, M; Sukkar, M; Xie, S; Issa, R; Mitchell, J; Johnson, M; Chung, KF |
